Newsletter Signup x
Rhabdomyosarcoma (RMS) is a childhood cancer that develops in muscle, with 50 new cases every year in the UK. Older children in particular have a poor outlook and we need to improve our understanding of the disease in order to develop new approaches to treatment. Professor Birch is carrying out a detailed investigation of the genetic mutations underlying RMS development, which we hope, ultimately, will direct new, personalised treatment strategies.
This research project on rhabdomyosarcoma has been successfully completed. Your donations allow us to fund ground-breaking research that can improve treatments given to children with cancer. Thank you. Your help allows us to continue to find ways to drive up the chances of survival for children with cancer and reduce the toxic side effects that can affect the rest of their lives.
Identification of new genetic changes in rhabdomyosarcoma
Professor Jill Birch
University of Manchester
Manchester M13 9PL
1 June 2013
40 months
£96,816
Patient Story – Harry E
Harry was diagnosed with embryonal rhabdomyosarcoma on 24 March 2011 when he was four years old. Here, his mum
Read moreTargeting short pieces of genetic code to treat malignant germ cell tumours
The group of tumours known as malignant germ cell tumours occur in a number of different places in the
Read more